Skip to main content
News Icon

COVIMMUNE being funded

A new consortium COVIMMUNE under the direction of Prof. Eicke Latz, speaker of the cluster of Excellence ImmunoSensation2 is being funded with around 2 Million Euros by the Federal Ministry of Education and Research (BMBF). The project "Understanding divergent host reactions to SARS-CoV-2 infections by precision immunology" (COVIMMUNE) brings together clinical researchers at the University Hospital Bonn who are involved in COVID-19 patient care with basic scientists with immunological expertise from the University of Bonn.

"We want to find out the connection between the mechanisms of the immune response to the SARS-CoV-2 infection and the clinical course of the disease," says Prof. Dr. Eicke Latz. Around two dozen personalities from disciplines such as virology, internal medicine, intensive care medicine, pulmonology, neurology, immunology, blood coagulation, bioinformatics and systems biology are involved. Together they want to contribute to a better understanding of the different course of the disease in SARS-CoV-2 infections. Prof. Natalio Garbi heads the sub-project of the consortium on adaptive immunity. He says: "We want to test whether the interaction of the innate and the acquired (adaptive) immune response is the key to eliminating the infection and developing long-term immunity without long-term health consequences."

The aim is to find out how the SARS-CoV-2 virus can trigger a misdirected immune response and what role this plays in severe COVID-19 disease courses. Furthermore, a clinical study will investigate which factors cause long-term damage to the lungs and the nervous system. Prof. Dr. Michael Heneka, whose sub-project in the consortium is looking at the secondary diseases of the lungs and the central nervous system caused by COVID-19, says: "It is not yet well understood how infection with the SARS-CoV-2 virus can trigger such secondary diseases. We want to examine these relationships in a clinical study in order to be able to offer better treatment options."


Contact

Prof. Dr. Eicke Latz

Institute of Innate Immunity, University of Bonn

Phone: 0228/287-51223

E-Mail: eicke.latz@uni-bonn.de

Related news

Nora Möhn

News categories: Publication

New Findings on Immunotherapy for a Rare Brain Infection

Progressive multifocal leukoencephalopathy (PML) is a rare but very serious brain disease. It is caused by the reactivation of the widespread JC virus when the immune system is severely weakened. There is currently no targeted antiviral therapy available, which is why new treatment approaches are urgently needed. In recent years, so-called immune checkpoint inhibitors have been increasingly used; these “unlock” the immune system and reactivate the body’s own immune cells. The results were recently published in the journal JAMA Neurology.
View entry
News Marvin Supercomputer

News categories: Honors & Funding

Two years of the Marvin Supercomputer: Researchers in Bonn present their projects

Two years after it went into operation, the University of Bonn celebrated the Marvin Supercomputer with a community event at the Research and Technology Center for Detector Physics (FTD). Researchers from various disciplines presented projects that had been carried out using high-performance computing and used the event as an opportunity for interdisciplinary exchange. A team lead by ImmunoSensation³ members Prof. Dr. Michael Hölzel (Institute of Experimental Oncology) and PD Dr. Gregor Hagelueken (Institute of Structural Biology) use Marvin to design new proteins.
View entry
Award Ceremony, SxDiagnostics

News categories: Honors & Funding

start2grow start-up competition awards “SxDiagnostics”

The “SxDiagnostics” project from the University of Bonn and the University Hospital Bonn (UKB) prevailed against over 100 competing teams in the start2grow competition and placed in the (shared) 4th to 10th spots. Start2grow is organized nationwide by the Dortmund Economic Development Agency and celebrated its 25th anniversary this year.
View entry

Back to the news overview